February 16, 2021
While powerful alliances are being forged in the private sector, there are calls though for more cooperation at government level.
“Now we’re facing a situation where overall capacity, whether it’s for the first steps of manufacturing or for fill and finish, they are scarce. And as a result, we need public agencies – so governments nationally or regionally, they have to come together and ask the question, if I have this capacity for something, how do I ensure that it remains coordinated between multiple vaccine manufacturers?” said Prashant Yadav, senior fellow at the Center for Global Development.